Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability – Hagens Berman
Telix Pharmaceuticals LtdTelix Pharmaceuticals Ltd(US:TLX) Globenewswire·2025-12-02 22:17

SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit following a series of regulatory setbacks and steep stock declines over the summer. Hagens Berman is actively investigating the allegations and urges Telix investors who suffered substantial losses to submit your losses now. Class Period: Feb. 21, 2025 – A ...